Follow the Money: Single-Cell Multiomics, Data Networks, Sec

Follow the Money: Single-Cell Multiomics, Data Networks, Security


April 1, 2021
By Bio-IT World Staff
April 1, 2021 | New investment funds for late-stage companies and public health. Next-gen genomic medicines and single-cell multiomics get cash, and PatientsLikeMe raises a new round of funding to expand.
 
$969M Investment Fund for Early to Late-Stage Companies
Foresite Capital, a multi-stage healthcare and life sciences investment firm, has announced its fifth and largest fundraise with $969 million in capital commitments, significantly oversubscribed above its original target. The offering comprises Foresite Capital Fund V, L.P. and Foresite Capital Opportunity Fund V, L.P. With these new funds, Foresite Capital is investing in emerging healthcare and life sciences companies at all stages that are solving some of the biggest inefficiencies and pain points of the $10 trillion global healthcare market. Foresite Capital now has ~$4 billion in assets under management. Press release.

Related Keywords

Deerfield , New York , United States , Georgia , Australia , Glasgow , Glasgow City , United Kingdom , Milan , Lombardia , Italy , Midlands , Leicestershire , Paris , France General , France , Alexandria , Al Iskandariyah , Egypt , North Pond , Dublin , Ireland , Michigan , London , City Of , Germany , Netherlands , Detroit , World Health Organization , Al Qahirah , Broadoak , Herefordshire , Tavistock , Devon , British , Georgian , Neil Hunt , Matthew Baker , Eyal Gura , Madelyn Trupkin Herzfeld , Hans Peter Kiem , Jeff Leerink , Anne Wojcicki , Ensoma Engenious , Asher Bio , Rory Mcilroy , Dexcel Pharma , George Roberts , Asher Biotherapeutics , Henry Kravis , Macarthur Foundation , Department Of Pure , M Research Grant On Fairness , Parasite Research , Spectrawave Inc , Foresite Capital Opportunity Fund , American University Kogod School Of Business , Digital Health , Foresite Capital Fund , Wellcome , M Investment Fund For Late , Fred Hutchinson Cancer Research Center , Health Catalyst Capital , M Investment Fund , Accelmed Fund , Ample Plus Fund , Small Business Innovation Research , Anthos Fund Asset Management , University Of Strathclyde , National Science Foundation , Philips Health Technology Ventures , Children Investment Fund Foundation , Health Network , Debiopharm Innovation Fund , Program On Fairness In Artificial Intelligence , Investments Ltd , Boxer Capital Of Tavistock Group , University Of Glasgow , Osage University Partners , Parity Responsible Technology Fund , Clocktower Technology Ventures , Doris Duke Charitable Foundation , Michigan Angel Fund , Intervention Insights Inc , Novo Holdings , Trapelo Health , Crossover Fund , Schusterman Foundation , Mount Sinai Team , C Health Equity Breakthrough Team , Jjdc Inc , Ford Foundation , Stage Companies , Global Health Investment Corporation , Mainstay Medical Holdings , University Of Washington School Medicine , Midlands Engine Investment Fund , Drug Administration , Novo Nordisk , Basecamp Fund , Sofinnova Partners Capital Fund , Melinda Gates Foundation , University Of Birmingham , Os Fund , Novartis , Biomedical Molecular Data Company , Kcrise Fund , World Data Network , Sofinnova Crossover Fund , Norcliffe Capital , Atain Specialty Insurance Company , M Investment Fund For Early To Late , United Kingdom Future Fund , Linear Diagnostics Ltd , Sixty Health , Netflix , British Business Bank , Investment Fund , Foresite Capital , Late Stage Healthcare , Digital Health Commercial Stage , Venture Fund , Improved Global Public , Investment Fund Foundation , Dalio Philanthropies , Anthos Fund , Asset Management , Casdin Capital , Johnson Innovation , Launch Implantable Neurostimulation , Medical Holdings , Ally Bridge Group , Sofinnova Partners , Capital Fund , Fountain Healthcare , Chronic Low Back Pain , Novel Host Response , Northpond Ventures , Khosla Ventures , Think Health , Insight Partners , Salesforce Ventures , Lead Edge Capital , Novel Synthetic Lethal Cancer , Janus Henderson Investors , Acuta Capital Partners , Avidity Partners , Caas Capital Management , Lightstone Ventures , Next Gen Genomic , F Prime Capital , Takeda Ventures , Viking Global Investors , Cormorant Asset Management , Alexandria Venture , Washington School , Real World Data , Learning Health Network , Precision Medicine Platform , Intervention Insights , Duquesne Family , Catalio Capital Management , Viola Ventures , Annotated Multi Omic Immune Cell Atlas , Dropprint Genomics , San Francisco Based , Third Rock Ventures , Boxer Capital , Tavistock Group , Minder Systems , Remote Patient , Canaan Partners , Next Phase , Alta Partners , Hambrecht Ducera Growth Ventures , Optum Ventures , Symphony Ventures , Seed Investments , Qure Ventures , Madelyn Trupkin , Surgical Intelligence , Blumberg Capital , Stageone Ventures , Kdt Ventures , Netflix Chief Product Officer Neil Hunt , Zebra Medical Vision , Co Founder Eyal Gura , Medical Data Management , Hewlett Packard Enterprise , Great North Labs , Argonautic Ventures , Convertible Loan , Future Fund , British Business , Deerfield Management , Seed Round For Private Data Sharing , Dolby Family Ventures , Okta Ventures , Nextgen Venture Partners , Operator Partners , Wavemaker Three Sixty Health ,

© 2025 Vimarsana